دورية أكاديمية

Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.

التفاصيل البيبلوغرافية
العنوان: Results of the first phase I clinical trial of the novel II-key hybrid preventive HER-2/neu peptide (AE37) vaccine.
المؤلفون: Holmes JP, Benavides LC, Gates JD, Carmichael MG, Hueman MT, Mittendorf EA, Murray JL, Amin A, Craig D, von Hofe E, Ponniah S, Peoples GE
المصدر: Journal of Clinical Oncology; 7/10/2008, Vol. 26 Issue 20, p3426-3433, 8p
قاعدة البيانات: Supplemental Index